Sign up USA
Proactive Investors - Run By Investors For Investors
Market: NASDAQ
52-week High/Low: $5.75 / $1.58
Sector: Pharma & Biotech
Market Cap: $93.13M
AcelRx Pharmaceuticals

AcelRx Pharmaceuticals

AcelRx Pharmaceuticals is a development-stage specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute pain. The Company's lead product candidate, Zalviso, is intended for the management of moderate-to-severe acute pain in hospitalized adult patients.

AcelRx Pharmaceuticals

Interactive graph

col 3
col 4
col 5
col 6

AcelRx Pharmaceuticals Timeline

Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use